PortfoliosLab logo
FBTCX vs. MSFT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between FBTCX and MSFT is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

FBTCX vs. MSFT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Microsoft Corporation (MSFT). The values are adjusted to include any dividend payments, if applicable.

-15.00%-10.00%-5.00%0.00%5.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-16.89%
0.41%
FBTCX
MSFT

Key characteristics

Sharpe Ratio

FBTCX:

-0.31

MSFT:

0.55

Sortino Ratio

FBTCX:

-0.29

MSFT:

0.83

Omega Ratio

FBTCX:

0.96

MSFT:

1.11

Calmar Ratio

FBTCX:

-0.19

MSFT:

0.71

Martin Ratio

FBTCX:

-0.77

MSFT:

1.54

Ulcer Index

FBTCX:

8.11%

MSFT:

7.11%

Daily Std Dev

FBTCX:

19.96%

MSFT:

20.06%

Max Drawdown

FBTCX:

-61.27%

MSFT:

-69.39%

Current Drawdown

FBTCX:

-33.02%

MSFT:

-7.89%

Returns By Period

In the year-to-date period, FBTCX achieves a -4.13% return, which is significantly lower than MSFT's 1.79% return. Over the past 10 years, FBTCX has underperformed MSFT with an annualized return of -0.61%, while MSFT has yielded a comparatively higher 26.89% annualized return.


FBTCX

YTD

-4.13%

1M

-8.73%

6M

-16.79%

1Y

-6.34%

5Y*

-2.31%

10Y*

-0.61%

MSFT

YTD

1.79%

1M

-1.91%

6M

-1.47%

1Y

9.74%

5Y*

21.89%

10Y*

26.89%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

FBTCX vs. MSFT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FBTCX
The Risk-Adjusted Performance Rank of FBTCX is 22
Overall Rank
The Sharpe Ratio Rank of FBTCX is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of FBTCX is 22
Sortino Ratio Rank
The Omega Ratio Rank of FBTCX is 22
Omega Ratio Rank
The Calmar Ratio Rank of FBTCX is 22
Calmar Ratio Rank
The Martin Ratio Rank of FBTCX is 22
Martin Ratio Rank

MSFT
The Risk-Adjusted Performance Rank of MSFT is 6262
Overall Rank
The Sharpe Ratio Rank of MSFT is 6666
Sharpe Ratio Rank
The Sortino Ratio Rank of MSFT is 5555
Sortino Ratio Rank
The Omega Ratio Rank of MSFT is 5555
Omega Ratio Rank
The Calmar Ratio Rank of MSFT is 7373
Calmar Ratio Rank
The Martin Ratio Rank of MSFT is 6363
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FBTCX vs. MSFT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Microsoft Corporation (MSFT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for FBTCX, currently valued at -0.31, compared to the broader market-1.000.001.002.003.004.00-0.310.55
The chart of Sortino ratio for FBTCX, currently valued at -0.29, compared to the broader market0.005.0010.00-0.290.83
The chart of Omega ratio for FBTCX, currently valued at 0.96, compared to the broader market1.002.003.004.000.961.11
The chart of Calmar ratio for FBTCX, currently valued at -0.19, compared to the broader market0.005.0010.0015.0020.00-0.190.71
The chart of Martin ratio for FBTCX, currently valued at -0.77, compared to the broader market0.0020.0040.0060.0080.00-0.771.54
FBTCX
MSFT

The current FBTCX Sharpe Ratio is -0.31, which is lower than the MSFT Sharpe Ratio of 0.55. The chart below compares the historical Sharpe Ratios of FBTCX and MSFT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00AugustSeptemberOctoberNovemberDecember2025
-0.31
0.55
FBTCX
MSFT

Dividends

FBTCX vs. MSFT - Dividend Comparison

FBTCX's dividend yield for the trailing twelve months is around 2.99%, more than MSFT's 0.72% yield.


TTM20242023202220212020201920182017201620152014
FBTCX
Fidelity Advisor Biotechnology Fund Class C
2.99%2.87%0.00%0.00%0.03%0.00%0.00%0.00%0.00%0.00%5.73%2.75%
MSFT
Microsoft Corporation
0.72%0.73%0.74%1.06%0.68%0.94%1.20%1.69%1.86%2.37%2.33%2.48%

Drawdowns

FBTCX vs. MSFT - Drawdown Comparison

The maximum FBTCX drawdown since its inception was -61.27%, smaller than the maximum MSFT drawdown of -69.39%. Use the drawdown chart below to compare losses from any high point for FBTCX and MSFT. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-33.02%
-7.89%
FBTCX
MSFT

Volatility

FBTCX vs. MSFT - Volatility Comparison

Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a higher volatility of 7.88% compared to Microsoft Corporation (MSFT) at 6.05%. This indicates that FBTCX's price experiences larger fluctuations and is considered to be riskier than MSFT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%5.00%6.00%7.00%8.00%AugustSeptemberOctoberNovemberDecember2025
7.88%
6.05%
FBTCX
MSFT